Authors: NAKAGAWA H FUJITA T KUBO S TOKIYOSHI K YAMADA M KANAYAMA T HAGIWARA Y NAKANOMYO H HIRAOKA M

Citation: H. Nakagawa et al., DIFFERENCE IN COOP PENETRATION INTO CSF BETWEEN SELECTIVE INTRAARTERIAL CHEMOTHERAPY IN PATIENTS WITH MALIGNANT GLIOMA AND INTRAVENOUS OR INTRACAROTID ADMINISTRATION IN PATIENTS WITH METASTATIC BRAIN-TUMOR, Cancer chemotherapy and pharmacology, 37(4), 1996, pp. 317-326

Authors: KIMURA M UMEMURA K IKEDA Y KOSUGE K MIZUNO A NAKANOMYO H OHASHI K NAKASHIMA M

Citation: M. Kimura et al., PHARMACOKINETICS AND PHARMACODYNAMICS OF (+ -)-SOTALOL IN HEALTHY MALE-VOLUNTEERS/, British journal of clinical pharmacology, 42(5), 1996, pp. 583-588

Authors: SHIMIZU T HIRAOKA M NAKANOMYO H

Citation: T. Shimizu et al., ENANTIOSELECTIVE DETERMINATION OF SOTALOL ENANTIOMERS IN BIOLOGICAL-FLUIDS USING HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY, Journal of chromatography B. Biomedical applications, 674(1), 1995, pp. 77-83

Authors: OHTSU T SASAKI Y TAMURA T MIYATA Y NAKANOMYO H NISHIWAKI Y SAIJO N

Citation: T. Ohtsu et al., CLINICAL PHARMACOKINETICS AND PHARMACODYNAMICS OF PACLITAXEL - A 3-HOUR INFUSION VERSUS A 24-HOUR INFUSION, Clinical cancer research, 1(6), 1995, pp. 599-606

Authors: MASE H HIRAOKA M SUZUKI A NAKANOMYO H

Citation: H. Mase et al., DETERMINATION OF NEW ANTICANCER DRUG, PAC LITAXEL, IN BIOLOGICAL-FLUIDS BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY, Yakugaku zasshi, 114(5), 1994, pp. 351-355